Nasal vaccines for COVID-19 are still in early development.
Paul Biris/Moment via Getty Images
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
Insect bites or stings, like the one on this person’s hand, are a manifestation of inflammation.
Suthep Wongkhad/EyeEm via Getty Images
Inflammation is a complicated and important part of how the immune system responds to threats to the body. But when the inflammatory response goes awry, it can lead to serious problems.
Rheumatoid arthritis leads to painful joint inflammation, often in the hands and wrists.
Peter Dazeley/The Image Bank via Getty Images
A new species of bacteria that doesn’t normally live in the gut may trigger an immune response so strong that it spreads to the joints.
Broadly neutralizing antibodies are able to recognize multiple strains of HIV at once.
Naeblys/iStock via Getty Images Plus
Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
It is safe to get the newly formulated COVID-19 booster shot and the flu shot at the same time.
SDI Productions/ E+ via Getty Images
When COVID-19 and the flu co-infect, it’s ‘flurona.’ But such cases are rare, and there are effective ways to protect yourself from both viruses.
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
Approximately 30% of people who get COVID-19 develop long-term symptoms, or long COVID-19.
Boy Anupong/Moment via Getty Images
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
Investigators in Florida traced a listeria outbreak to ice cream.
Graiki/Moment via Getty Images
Listeria causes serious illness and food recalls nearly every year.
With mask mandates and vaccine requirements lifting, public health information remains crucial so people can weigh their own COVID-19 risks.
THE CANADIAN PRESS/Nathan Denette
To help people make informed decisions about ongoing COVID-19 risks, public health messaging needs to adapt as the pandemic evolves, just as immune systems adapt to new viruses and variants.
Researchers can test blood samples taken for other reasons to see if patients have previously had COVID-19.
Don Bartletti/Los Angeles Times via Getty Images
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Although the COVID-19 vaccines have saved millions of lives, they have been insufficient at preventing breakthrough infections.
Andriy Onufriyenko/Moment via Getty Images
Research suggests that too-frequent immunizations may lead to a phenomenon called “immune exhaustion.”
While many immunocompromised and high-risk patients may benefit from AstraZeneca’s Evusheld, drug distribution and access have been uneven.
AP Photo/Ted S. Warren
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
Researchers are working to develop vaccines that provide long-term immune protection from COVID-19.
Marko Geber/Digital Vision via Getty Images
Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
New variants of SARS-CoV-2, the virus that causes COVID-19, arise through mutations when the virus replicates in an infected host’s cells.
(NIAID, cropped from original)
COVID-19 variants are the products of the evolution of the SARS-CoV-2 virus. They arise via mutations, but other forces also have roles to play in the generation and transmission of variants.
Immunologists are studying how the SARS-CoV-2 virus interacts with antibodies in the immune system.
Christoph Burgstedt/Science Photo Library via Getty Images
COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
AAP Image/Bianca De Marchi
Infection seems to add a boost to immunity – but vaccination is still vital and breakthrough infections should be avoided as much as possible.
Preliminary research suggests that the omicron variant may potentially induce a robust immune response.
Olga Siletskaya/Moment via Getty Images
Some of the omicron variant’s unique properties – such as its ability to spread rapidly while causing milder COVID-19 infections – could usher in a new phase of the pandemic.
Understanding how much protection a vaccine offers is not as simple as it sounds.
Andriy Onufriyenko/Moment via Getty Images
For a number of reasons, as time goes on vaccines become less effective. So how do researchers calculate how well vaccines are working?
The key to rapid antigen testing is to test early in the course of COVID-19 infection, ideally several times 24 hours apart.
VioletaStoimenova/E+ via Getty Images
Knowing when and how often to use rapid tests is key to getting an accurate picture of your COVID-19 status.
We won’t know whether Omicron evades COVID vaccines for another few weeks. Here’s why.